A phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf

by Chalmers, James D., Gupta, Abhya, Chotirmall, Sanjay Haresh, Armstrong, April, Eickholz, Peter, Hasegawa, Naoki, McShane, Pamela J., O'Donnell, Anne E., Shteinberg, Michal, Watz, Henrik, Eleftheraki, Anastasia, Diefenbach, Claudia, Sauter, Wiebke
Published 2024

Research priorities to address the global burden of chronic obstructive pulmonary disease (COPD) in the next decade

by Adeloye, Davies, Agarwal, Dhiraj, Barnes, Peter J., Bonay, Marcel, van Boven, Job F., Bryant, Jamie, Caramori, Gaetano, Dockrell, David, D'Urzo, Anthony, Ekstrom, Magnus, Erhabor, Gregory, Esteban, Cristobal, Greene, Catherine M., Hurst, John, Juvekar, Sanjay, Khoo, Ee Ming, Ko, Fanny W., Lipworth, Brian, Lopez-Campos, Jose L., Maddocks, Matthew, Mannino, David M., Martinez, Fernando J., Martinez-Garcia, Miguel A., McNamara, Renae J., Miravitlles, Marc, Pinnock, Hilary, Pooler, Alison, Quint, Jennifer K., Schwarz, Peter, Slavich, George M., Song, Peige, Tai, Andrew, Watz, Henrik, Wedzicha, Jadwiga A., Williams, Michelle C., Campbell, Harry, Sheikh, Aziz, Rudan, Igor
Published 2021